Searchable abstracts of presentations at key conferences in endocrinology

ea0063gp73 | Thyroid Autoimmune Disorders | ECE2019

Clinical experiences in autoimmune polyglandular diseases

Pham-Dobor Greta , Bajnok Laszlo , Bodis Beata , Gergics Marin , Nemes Orsolya , Rucz Karoly , Mezősi Emese

Introduction: The autoimmune polyglandular syndrome is a complex, heterogeneous disease in which autoimmune diseases of endocrine and non-endocrine organs can occur. There are 4 subgroups: the early-onset APS I develops due to the mutation of the gene AIRE and characterized by the presence of Addison’s disease (AD), mucocutan candidiasis and hypoparathyroidism; the APS II is defined by the appearance of AD and autoimmune thyroid diseases (AITDs) and/or diabetes mellitus; ...

ea0063gp169 | Obesity (1) | ECE2019

The role of copeptin and cortisol in critically ill patients

Gergics Marin , Pham-Dobor Greta , Tarjanyi Zita , Montsko Gergely , Kőszegi Tamas , Mezősi Emese , Bajnok Laszlo

Introduction: Both cortisol and vasopressin are stress hormones. Earlier, our group demonstrated that serum concentrations of free cortisol at admissions to the Intensive Care Unit (ICU) were independent predictors of survival in critically ill patients. Other investigators have demonstrated that serum copeptin, a surrogate marker of vasopressin may also be a predictive factor in this patient population. The aim of our present study was to compare the prognostic roles of serum...

ea0063p756 | Thyroid 2 | ECE2019

Systematic review and meta-analysis of occurrence of other autoimmune diseases in autoimmune polyglandular syndrome type II and type III

Pham-Dobor Greta , Bajnok Laszlo , Gergics Marin , Hanak Lilla , Hegyi Peter , Marta Katalin , Mezősi Emese

Introduction: The autoimmune polyglandular syndrome (APS) is a complex, heterogeneous condition in which autoimmune diseases (AIs) of endocrine and non-endocrine organs can occur. There are four subgroups. The majority of patients are categorized as having APS II or APS III. In APS II, patients have Addison’s disease (AD) and autoimmune thyroid diseases (AITDs) or type I. diabetes mellitus (T1DM), while in the APS III, AITDs are combined with other autoimmune illnesses ex...

ea0070aep974 | Thyroid | ECE2020

Humoral changes during resolution of short term severe hypothyroidism

Gergics Marin , Pham-Dobor Greta , Horváth-Szalai Zoltán , Kőszegi Tamás , Mezosi Emese , Bajnok Laszlo

Introduction: Significant hyponatremia may evolve in hypothyroidism, when however, elevated ADH levels have not been consistently demonstrated. On the other hand, it was shown that thyroid hormone substitution suppresses ADH, and its surrogate marker copeptin secretion. The aim of our present study was to investigate the possible humoral changes in a special model of resolution of short term severe hypothyroidism in differentiated thyroid cancer (DTC) patients.<p class="ab...